Bijonex Nasal Spray (Mometasone Furoate)

Adult use

1. Allergic Rhinitis Adults (including the elderly) and adolescents aged 12 years and older: Generally, 2 sprays in each nostril once a day (total daily dose 0.2 mg). If symptoms are relieved, the maintenance dose can be reduced to 1 spray in each nostril (total daily dose 0.1 mg). If symptoms are not relieved, the dose can be increased to a maximum of 4 sprays in each nostril once a day (total daily dose 0.4 mg).

Child use

2. Allergic Rhinitis Children aged 2 to 11 years: Generally, 1 spray in each nostril once a day (total daily dose 0.1 mg).

This medication is a spray form applied inside the nose and is mainly used for allergic rhinitis or when there is inflammation in the nose. However, it should not be used if there is an allergy to this medication or an untreated infection inside the nose. If there has been recent nasal surgery or if there is an open wound in the nose, this medication should not be used until the wound is completely healed. Additionally, it is safer not to use in children under 2 years old. Patients with tuberculosis or severe infections, those with ocular herpes, or individuals with frequent nosebleeds or at risk for chickenpox or measles should use this medication with caution. Women who are pregnant or breastfeeding should also consult with a doctor before use. Side effects such as headache, nosebleed, cough, sore throat, and viral infections may occur while using this medication, and rarely severe reactions like allergic response or breathing difficulties can happen. Long-term use at high doses can have systemic effects, so caution is advised. If inflammation or injury occurs inside the nose, use should be stopped and a doctor consulted. This medication protects and restores the nasal mucosa, but it is advisable to routinely check the condition of the nose during prolonged use. Patients at risk for chickenpox or measles should be cautious about infection prevention and should inform healthcare providers immediately if an infection is suspected. Effectiveness may not be immediate within 48 hours of first use. In children, growth rate may slow, so growth status should be monitored regularly during use. This medication can cause specific fungal infections, so it should be discontinued immediately if symptoms of Candida infection in the nose or throat appear. Patients with a history of glaucoma or cataracts should undergo eye examinations during use In the case of overdose, no specific treatment is usually required, but symptoms related to steroid overdosage may occur, so caution should be applied. Before use, the container should be shaken well, and if not used for a long time, a test spray should be performed; care should be taken not to spray directly into the eyes or nasal septum. This medication should be kept out of the reach of children and is known not to significantly affect driving or operating machinery.

Serious side effects

Hives, severe swelling (angioedema), tightness in the chest, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blistering, skin peeling, pain in oral/ocular mucosa, severe skin reactions, asthma attacks, visual disturbances, paralysis, severe neurological symptoms, markedly decreased urine output, severe systemic edema, increased blood pressure, severe swelling or urination abnormalities, jaundice, generalized severe lethargy, liver issues.

Mild side effects

Headache, viral infection, pharyngitis, nosebleed/bloody mucus, cough, upper respiratory infection, menstrual disorders, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, dyspepsia, otalgia, cold symptoms, myalgia, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), positive fungal test in the nose, throat.

This medication should be stored in a sealed container to prevent air or moisture from entering. The appropriate storage temperature is between 2°C and 25°C in a cool place. Proper storage will help maintain the drug's effectiveness and safety.

Appearance

An opaque suspension that is white or almost white in a container that dispenses a fixed amount per spray.

Package unit

18 milliliters/bottle